Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Omija berry (Schisandra chinensis) contains unique lignans like schisandrins and abundant polyphenols that provide potent antioxidant activity through DPPH radical scavenging and enzyme inhibition. These compounds significantly inhibit α-amylase by 74% and α-glucosidase at IC50 <1.0 mg/mL while enhancing mitochondrial activity and promoting brown fat gene expression.
Reported Benefits (Provisional)
Origin & History
Omija berry (Schisandra chinensis), a deciduous woody vine, is native to Northeast Asia, particularly Korea, China, and Russia, thriving in temperate forests and mountain slopes. Known as the "five-flavor berry," it is a revered adaptogen in traditional medicine, valued for its comprehensive support of vitality and resilience.
Research Narrative (Provisional)
Extensive research, including in vitro, animal, and some human studies, validates Omija berry's adaptogenic, hepatoprotective, and neuroprotective effects, primarily attributed to its unique lignan compounds. Studies also support its role in immune modulation and respiratory wellness.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Lignans (Schisandrin, Gomisin): Key adaptogenic compounds supporting liver, cognitive, and stress response. - Vitamin C: Enhances immunity and antioxidant protection. - Flavonoids & Polyphenols: Provide broad-spectrum antioxidant and anti-inflammatory benefits. - Essential Minerals (Potassium, Calcium, Magnesium): Support nerve, muscle, and bone health. - Organic Acids: Contribute to its unique flavor profile and metabolic support.
Reported Mechanism (Provisional)
Omija's lignans (schisandrins) and polyphenols exert antioxidant effects via DPPH radical scavenging and molybdenum-reducing antioxidant power (MRAP), while inhibiting key digestive enzymes α-amylase and α-glucosidase. The compounds upregulate brown fat genes including PPARα, CIDEA, and COX8β, promoting beige adipocyte formation. Additionally, they enhance AMPK/Akt/IRS phosphorylation and increase GLUT2 expression for improved glucose metabolism.
Clinical Narrative (Provisional)
Human clinical evidence remains limited, with most research confined to preclinical studies. One clinical trial using an Omija-soybean mixture in type 2 diabetes patients demonstrated synergistic improvements in glucose control and insulin sensitivity, though specific quantitative outcomes were not detailed. In vitro studies consistently show dose-dependent antioxidant activity at 10-100 μg/mL concentrations, equivalent to 1 μM Trolox. Animal studies demonstrate significant improvements in metabolic markers including reduced fasting glucose, cholesterol, and triglycerides, though larger human trials are needed to confirm therapeutic efficacy.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.